Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IMPEL PHARMACEUTICALS INC (IMPL)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-05-20 | Dec-31-19 |
| | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 8.3 | | | | | | |
| Asset turnover | 0.1 | | 0.0 | | 0.0 | | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -2351.4% | | | | | | |
| ROIC (including intangibles) | -928.4% | | 3785.8% | | 870.6% | | 3443.5% |
| ROE | 184.3% | | -132.9% | | 701.7% | | -122.5% |
| ROA | -91.9% | | -71.3% | | -375.9% | | -98.4% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 214.8 | | 738.7 | | | | |
| Days payables outstanding | 342.4 | | 3,363.2 | | | | |
| Days inventory outstanding | 87.6 | | | | | | |
| Cash conversion cycle | -40.0 | | -2,624.4 | | | | |
|